They don't own the office or manufacturing warehouse according to others research here. Not sure they even own the sheep.
At the rate of take up cardiocel doesn't appear to be all we had hoped. It's also more than half way through its patent period, right? 20 years?
- Forums
- ASX - By Stock
- AVR
- Require regular updates
Require regular updates, page-14
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.10 |
Change
-0.810(8.17%) |
Mkt cap ! $196.8M |
Open | High | Low | Value | Volume |
$9.50 | $9.77 | $9.01 | $212.2K | 22.63K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 298 | $9.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.85 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 432 | 9.200 |
1 | 397 | 9.100 |
1 | 298 | 9.010 |
1 | 1000 | 9.000 |
1 | 200 | 8.700 |
Price($) | Vol. | No. |
---|---|---|
8.570 | 98 | 1 |
9.000 | 112 | 1 |
9.100 | 3555 | 1 |
9.850 | 1000 | 1 |
9.910 | 231 | 2 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online